Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 144 (1998), 325-332
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charland, N.
Right arrow Articles by Gottschalk, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charland, N.
Right arrow Articles by Gottschalk, M.
Agricola
Right arrow Articles by Charland, N.
Right arrow Articles by Gottschalk, M.

microbiology, Vol 144, 325-332, Copyright © 1998 by Society for General Microbiology


ARTICLES

Streptococcus suis serotype 2 mutants deficient in capsular expression

N Charland, J Harel, M Kobisch, S Lacasse and M Gottschalk
Groupe de Recherche sur les Maladies Infectieuses du Porc, Faculte de medecine veterinaire, Universite de Montreal, Quebec, Canada.

Streptococcus suis serotype 2 is responsible for a wide variety of porcine infections. In addition, it is considered a zoonotic agent. Knowledge about the virulence factors for this bacterium is limited but its polysaccharide capsule is thought to be one of the most important. Transposon mutagenesis with the self-conjugative transposon Tn916 was used to obtain acapsular mutants from the virulent S. suis type 2 reference strain S735. Clones were screened by colony-dot ELISA with a monoclonal antibody specific for a type 2 capsular epitope and clones that failed to react with the antibody were characterized. Two mutants, 2A and 79, having one and two Tn916 insertions respectively, were chosen for further characterization. Absence of capsule was confirmed by coagglutination, capillary precipitation and capsular reaction tests and by transmission electron microscopy. Absence of capsular polysaccharides correlated with increased hydrophobicity and phagocytosis by both murine macrophages and porcine monocytes compared to the wild-type strain. Furthermore, both mutants were shown to be avirulent in murine and pig models of infection. Finally, mutant 2A was readily eliminated from circulation in mice compared to the wild-type strain, which persisted more than 48 h in blood. Thus, isogenic mutants defective in capsule production demonstrate the importance of capsular polysaccharides as a virulence factor for S. suis type 2.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
N. Fittipaldi, T. Sekizaki, D. Takamatsu, J. Harel, M. d. l. C. Dominguez-Punaro, S. Von Aulock, C. Draing, C. Marois, M. Kobisch, and M. Gottschalk
D-Alanylation of Lipoteichoic Acid Contributes to the Virulence of Streptococcus suis
Infect. Immun., August 1, 2008; 76(8): 3587 - 3594.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y. Li, M. Gottschalk, M. Esgleas, S. Lacouture, J. D. Dubreuil, P. Willson, and J. Harel
Immunization with Recombinant Sao Protein Confers Protection against Streptococcus suis Infection
Clin. Vaccine Immunol., August 1, 2007; 14(8): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Graveline, M. Segura, D. Radzioch, and M. Gottschalk
TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness
Int. Immunol., April 1, 2007; 19(4): 375 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
P. Gruening, M. Fulde, P. Valentin-Weigand, and R. Goethe
Structure, Regulation, and Putative Function of the Arginine Deiminase System of Streptococcus suis
J. Bacteriol., January 15, 2006; 188(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M.-C. Jobin, G. Martinez, J. Motard, M. Gottschalk, and D. Grenier
Cloning, Purification, and Enzymatic Properties of Dipeptidyl Peptidase IV from the Swine Pathogen Streptococcus suis
J. Bacteriol., January 15, 2005; 187(2): 795 - 799.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Segura, M. Gottschalk, and M. Olivier
Encapsulated Streptococcus suis Inhibits Activation of Signaling Pathways Involved in Phagocytosis
Infect. Immun., September 1, 2004; 72(9): 5322 - 5330.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Vanier, M. Segura, P. Friedl, S. Lacouture, and M. Gottschalk
Invasion of Porcine Brain Microvascular Endothelial Cells by Streptococcus suis Serotype 2
Infect. Immun., March 1, 2004; 72(3): 1441 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. C. Fontaine, J. Perez-Casal, and P. J. Willson
Investigation of a Novel DNase of Streptococcus suis Serotype 2
Infect. Immun., February 1, 2004; 72(2): 774 - 781.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M.-C. Jobin, J. Brassard, S. Quessy, M. Gottschalk, and D. Grenier
Acquisition of Host Plasmin Activity by the Swine Pathogen Streptococcus suis Serotype 2
Infect. Immun., January 1, 2004; 72(1): 606 - 610.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Segura and M. Gottschalk
Streptococcus suis Interactions with the Murine Macrophage Cell Line J774: Adhesion and Cytotoxicity
Infect. Immun., August 1, 2002; 70(8): 4312 - 4322.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. J. King, P. J. Heath, I. Luque, C. Tarradas, C. G. Dowson, and A. M. Whatmore
Distribution and Genetic Diversity of Suilysin in Streptococcus suis Isolated from Different Diseases of Pigs and Characterization of the Genetic Basis of Suilysin Absence
Infect. Immun., December 1, 2001; 69(12): 7572 - 7582.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. E. Smith, H. Buijs, H. J. Wisselink, N. Stockhofe-Zurwieden, and M. A. Smits
Selection of Virulence-Associated Determinants of Streptococcus suis Serotype 2 by In Vivo Complementation
Infect. Immun., March 1, 2001; 69(3): 1961 - 1966.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. Lalonde, M. Segura, S. Lacouture, and M. Gottschalk
Interactions between Streptococcus suis serotype 2 and different epithelial cell lines
Microbiology, August 1, 2000; 146(8): 1913 - 1921.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
N. Charland, V. Nizet, C. E. Rubens, K. S. Kim, S. Lacouture, and M. Gottschalk
Streptococcus suis Serotype 2 Interactions with Human Brain Microvascular Endothelial Cells
Infect. Immun., February 1, 2000; 68(2): 637 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Gottschalk, R. Higgins, and S. Quessy
Dilemma of the Virulence of Streptococcus suis Strains
J. Clin. Microbiol., December 1, 1999; 37(12): 4202 - 4203.
[Full Text]


Home page
Infect. Immun.Home page
M. Segura, J. Stankova, and M. Gottschalk
Heat-Killed Streptococcus suis Capsular Type 2 Strains Stimulate Tumor Necrosis Factor Alpha and Interleukin-6 Production by Murine Macrophages
Infect. Immun., September 1, 1999; 67(9): 4646 - 4654.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. E. Smith, M. Damman, J. van der Velde, F. Wagenaar, H. J. Wisselink, N. Stockhofe-Zurwieden, and M. A. Smits
Identification and Characterization of the cps Locus of Streptococcus suis Serotype 2: the Capsule Protects against Phagocytosis and Is an Important Virulence Factor
Infect. Immun., April 1, 1999; 67(4): 1750 - 1756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1998 Society for General Microbiology.